Baird Maintains Outperform on Medpace Hldgs, Raises Price Target to $312
Portfolio Pulse from Benzinga Newsdesk
Baird analyst Eric Coldwell has maintained an Outperform rating on Medpace Holdings (NASDAQ:MEDP) and increased the price target from $302 to $312.
January 17, 2024 | 7:32 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Baird analyst Eric Coldwell has reaffirmed Medpace Holdings' Outperform rating and raised the price target to $312, indicating a positive outlook on the stock.
The increase in price target by Baird suggests a bullish outlook on Medpace Holdings, which could lead to increased investor confidence and a potential short-term rise in the stock price.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100